mySugr Revenue and Competitors
Estimated Revenue & Valuation
- mySugr's estimated annual revenue is currently $28.3M per year.
- mySugr's estimated revenue per employee is $154,000
Employee Data
- mySugr has 184 Employees.
- mySugr grew their employee count by 1% last year.
mySugr Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $16M | 114 | -31% | $106.2M | N/A |
What Is mySugr?
mySugr specializes in app-based, all-around care for people with diabetes made by people with diabetes. Our digital diabetes solution combines diabetes coaching, therapy management, diabetes supplies, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes.
keywords:Mobile, Healthcare, Health Care Information Technology, Mobile Health, Gamification, mHealth, Diabetes
N/A
Total Funding
184
Number of Employees
$28.3M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
mySugr News
health leadership team's prior experience building mySugr, a highly successful diabetes management app that was acquired by Roche in 2017.
Since founding MySugr in 2012, Westermann said diabetes care has transformed. We had the idea of a digital diabetes clinic 10 years ago, but it...
Before that, mySugr had another potential buyer: Livongo. "We were outbid," says Glen Tullman, one of Livongo's founders and a partner with...
mySugr, a popular digital diabetes management platform which emerged from Austria a few years ago, has been acquired by health giant Roche. It now becomes the heart of Roche Diabetes Care’s new patient-centered digital health services. Roche plans to maintain its acquisition as an open and indep ...
Other Companies in Vienna
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.1M | 184 | 27% | N/A |
#2 | N/A | 184 | 27% | N/A |
#3 | $15M | 189 | 26% | N/A |
#4 | $43.9M | 190 | 34% | N/A |
#5 | $23.8M | 198 | 27% | N/A |
